Table 4.
NOE | average
violation (Å) |
structures in
which found |
---|---|---|
terminal residues | ||
T1(11)H6-T1(11)H2′ | −1.12 | A, B, P |
T1(11)H6–H2″ | −0.60 | A, B, P |
T2(12)H5–H3′ | −0.80 | A, B, P |
T2H5-T1H1′ | −0.71 | A, B, P |
A7(17)H1′–A8(18)H4′ | −1.10 | A, B, P |
A7(17)H4′–A8(18)H8 | −0.64 | A, B |
A8(18)H8–H2″ | −0.68 | B, P |
adenine 7(17) | ||
A7(17)H8–H2″ | −0.99 | A, B, P |
A7(17)H8–H3′ | −0.66 | A, B, P |
A7(17)H5″–C6(16)H1′ | −0.91 | A, P |
A7(17)H5″–C6(16)H2′ | −1.10 | A, P |
A7(17)H4′–D35(25)H2A | −0.95 | A, B, P |
A7(17)H3′–D35(25)H2A | −0.58 | B, P |
chromophore side chain | ||
CPH23H1′OMe-C26HM6 | −2.30 | B, P |
CPH23H1′–C26HM6 | −1.59 | B, P |
C23(33)H4′–H4A/E | −2.56 | A, B, P |
C23(33)H5′–H4A/E | −1.15 | B, P |
C23(33)H1′–H4A/E | −0.61 | A, B, P |
C23(33)H5′–H1′OMe | −0.93 | B, P |
C23(33)H1′–H3′ | −1.19 | B, P |
C23(33)H1′–H4′ | −1.40 | B, P |
C16H4′–C23H4′ | −1.62 | B, P |
C33H1′OMe-H10 | −0.88 | A, B, P |
inter-drug | ||
B21(31)H2E–A22(32)H4 | −0.64 | A, B, P |
B21(31)H2E–A22(32)HM4 | −1.77 | A, B, P |
C23(33)H10-A22(32)H1 | −0.63 | A, P |
E24(34)HM6-A32(22)HM4 | −1.45 | A, B, P |
miscellaneous | ||
G3(13)H4′–H2′ | −0.86 | A, B, P |
B21(31)HM6-G14(4)H5′ | −1.09 | A, P |
C23(33)HM7-G13(3)H1′ | −0.63 | A, B, P |
Minimized average shift structures for each family, using fpc = 50 kcal mol−1 ppm−2.